Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Safety Communications Are Not Crisis Management Tools, FDA Says

Mar 26 2012

• By Sue Sutter

Related Content

Economic Superiority Claims, Manufacturer/Payer Relationships Ripe For Enforcement Scrutiny

Feb 06 2012

CDER To Pilot Test New Framework For Classifying Drug Safety Issues

Mar 26 2012

FDA To Continue Providing Emerging Safety Info, But Not Through Drug Watch

Apr 02 2007

Socially Adept: Pharma Companies Must Proactively Gauge Risk Tolerance For Online Promotions, Experts Advise

Apr 06 2011

Prilosec/Nexium Alert Is Debut Of FDA’s Early Communication Of Safety Issues

Aug 13 2007

Additional Topics

Safety Advertising, Marketing & Sales BioPharmaceutical

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window